Cacciatore, Jonathan J.
https://orcid.org/0000-0002-8691-6153
Mayo Clinic
Bristol-Myers Squibb (United States)
Citations 1
Results from the First Phase 1 Clinical Study of the B-Cell Maturation Antigen (BCMA) Nex T Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Kumar, Shaji , Liedtke, Michaela , Mailankody, Sham , Limones, Josiana, Das, Sharmila , Thorpe, Jerill , Cacciatore, Jonathan J. , Navarro, Garnet, Koegel, Ashley K., Burgess, Michael R., Hege, Kristen , Costa, Luciano J. , Atrash, Shebli , Kaur, Gurbakhash , Derman, Benjamin A. , Bergsagel, P. Leif , McCarthy, Philip L. , Chen, Yanping , Richard, Shambavi
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1360-1362
